Superparamagnetic Iron Oxide Labeling of Stem Cells for MRI Tracking and Delivery in Cardiovascular Disease

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2010 Aug 4

PMID 20680819

Citations 15

Authors

Dorota A Kedziorek

Dara L Kraitchman

Affiliations

Soon will be listed here.

Abstract

In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.

Citing Articles

Field switching of microfabricated metamagnetic FeRh MRI contrast agents.

Dodd S, Gudino N, Zadorozhnii O, Stano M, Hajducek J, Arregi J Sci Rep. 2025; 15(1):2779.

PMID: 39843509 PMC: 11754896. DOI: 10.1038/s41598-025-85384-6.

Exosome Traceability and Cell Source Dependence on Composition and Cell-Cell Cross Talk.

Hamzah R, Alghazali K, Biris A, Griffin R Int J Mol Sci. 2021; 22(10).

PMID: 34069542 PMC: 8161017. DOI: 10.3390/ijms22105346.

Tracking of Labelled Stem Cells Using Molecular MR Imaging in a Mouse Burn Model as an Approach to Regenerative Medicine.

Qadri Z, Righi V, Li S, Tzika A Adv J Mol Imaging. 2021; 11(1):1-15.

PMID: 33996249 PMC: 8118598. DOI: 10.4236/ami.2021.111001.

Noninvasive cell tracking using molecular imaging: A useful tool for developing mesenchymal stem cell-based cancer treatment.

Rajendran R, Jogalekar M, Gangadaran P, Ahn B World J Stem Cells. 2021; 12(12):1492-1510.

PMID: 33505597 PMC: 7789123. DOI: 10.4252/wjsc.v12.i12.1492.

In Vivo Tracking of Tissue Engineered Constructs.

Gil C, Tomov M, Theus A, Cetnar A, Mahmoudi M, Serpooshan V Micromachines (Basel). 2019; 10(7).

PMID: 31315207 PMC: 6680880. DOI: 10.3390/mi10070474.

References

Mani V, Briley-Saebo K, Itskovich V, Samber D, Fayad Z . Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med. 2005; 55(1):126-35. DOI: 10.1002/mrm.20739. View

Bulte J, Kraitchman D . Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17(7):484-99. DOI: 10.1002/nbm.924. View

de Vries I, Lesterhuis W, Barentsz J, Verdijk P, van Krieken J, Boerman O . Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol. 2005; 23(11):1407-13. DOI: 10.1038/nbt1154. View

Ebert S, Taylor D, Nguyen H, Kodack D, Beyers R, Xu Y . Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells. 2007; 25(11):2936-44. DOI: 10.1634/stemcells.2007-0216. View

Tallheden T, Nannmark U, Lorentzon M, Rakotonirainy O, Soussi B, Waagstein F . In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci. 2006; 79(10):999-1006. DOI: 10.1016/j.lfs.2006.05.021. View

Rad A, Janic B, Iskander A, Soltanian-Zadeh H, Arbab A . Measurement of quantity of iron in magnetically labeled cells: comparison among different UV/VIS spectrometric methods. Biotechniques. 2007; 43(5):627-8, 630, 632 passim. DOI: 10.2144/000112599. View

Sun R, Dittrich J, Le-Huu M, Mueller M, Bedke J, Kartenbeck J . Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol. 2005; 40(8):504-13. DOI: 10.1097/01.rli.0000162925.26703.3a. View

Cahill K, Germain S, Byrne B, Walter G . Non-invasive analysis of myoblast transplants in rodent cardiac muscle. Int J Cardiovasc Imaging. 2005; 20(6):593-8. DOI: 10.1007/s10554-004-3902-8. View

Cahill K, Gaidosh G, Huard J, Silver X, Byrne B, Walter G . Noninvasive monitoring and tracking of muscle stem cell transplants. Transplantation. 2004; 78(11):1626-33. DOI: 10.1097/01.tp.0000145528.51525.8b. View

10.

Frank J, Zywicke H, Jordan E, Mitchell J, Lewis B, Miller B . Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol. 2002; 9 Suppl 2:S484-7. DOI: 10.1016/s1076-6332(03)80271-4. View

11.

Janic B, Iskander A, Rad A, Soltanian-Zadeh H, Arbab A . Effects of ferumoxides-protamine sulfate labeling on immunomodulatory characteristics of macrophage-like THP-1 cells. PLoS One. 2008; 3(6):e2499. PMC: 2423478. DOI: 10.1371/journal.pone.0002499. View

12.

Amado L, Schuleri K, Saliaris A, Boyle A, Helm R, Oskouei B . Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol. 2006; 48(10):2116-24. DOI: 10.1016/j.jacc.2006.06.073. View

13.

Pawelczyk E, Arbab A, Pandit S, Hu E, Frank J . Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed. 2006; 19(5):581-92. DOI: 10.1002/nbm.1038. View

14.

Stuckey D, Carr C, Martin-Rendon E, Tyler D, Willmott C, Cassidy P . Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart. Stem Cells. 2006; 24(8):1968-75. DOI: 10.1634/stemcells.2006-0074. View

15.

Oude Engberink R, van der Pol S, Dopp E, de Vries H, Blezer E . Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology. 2007; 243(2):467-74. DOI: 10.1148/radiol.2432060120. View

16.

Walczak P, Ruiz-Cabello J, Kedziorek D, Gilad A, Lin S, Barnett B . Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine. 2007; 2(2):89-94. DOI: 10.1016/j.nano.2006.01.003. View

17.

Farrar C, Dai G, Novikov M, Rosenzweig A, Weissleder R, Rosen B . Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed. 2007; 21(5):453-63. PMC: 2629945. DOI: 10.1002/nbm.1209. View

18.

Kraitchman D, Heldman A, Atalar E, Amado L, Martin B, Pittenger M . In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003; 107(18):2290-3. DOI: 10.1161/01.CIR.0000070931.62772.4E. View

19.

Arbab A, Yocum G, Kalish H, Jordan E, Anderson S, Khakoo A . Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood. 2004; 104(4):1217-23. DOI: 10.1182/blood-2004-02-0655. View

20.

Arai T, Kofidis T, Bulte J, De Bruin J, Venook R, Berry G . Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t. Magn Reson Med. 2005; 55(1):203-9. DOI: 10.1002/mrm.20702. View